Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Cell Metabolism
|
December 8, 2022
Microbiome-derived metabolites counteract tumor-induced immunosuppression and boost immune checkpoint blockade
Hassane M Zarour
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2016
Reversing T-cell Dysfunction and Exhaustion in Cancer
Hassane M Zarour
Annual Review of Immunology
|
December 5, 2025
Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting
Hassane M Zarour, Giorgio Trinchieri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2022
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Diwakar Davar, Hassane M Zarour
Methods in Molecular Biology (Clifton, N.J.)
|
September 11, 2019
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors
Diwakar Davar, Hassane M Zarour
Clinics in Dermatology
|
April 24, 2013
Strategies to reverse melanoma-induced T-cell dysfunction
Julien Fourcade, Hassane M Zarour
Seminars in Cutaneous Medicine and Surgery
|
May 30, 2003
Melanoma vaccines: early progress and future promises
Hassane M Zarour, John M Kirkwood
Journal for Immunotherapy of Cancer
|
September 9, 2020
TIGIT in cancer immunotherapy
Joe-Marc Chauvin, Hassane M Zarour
Cellular and Molecular Bioengineering
|
July 10, 2026
Toward a Dual-Axis Model of Microbiome Modulation in Cancer Immunotherapy: Pathobiont Elimination and Functional Ecosystem Restoration
Diwakar Davar, Hassane M Zarour, Giorgio Trinchieri
Cell
|
April 17, 2026
Improving immunotherapy in solid tumors using FMT
Diwakar Davar, Hassane M Zarour, Georgio Trinchieri
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Cell Metabolism
|
December 8, 2022
Microbiome-derived metabolites counteract tumor-induced immunosuppression and boost immune checkpoint blockade
Hassane M Zarour
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2016
Reversing T-cell Dysfunction and Exhaustion in Cancer
Hassane M Zarour
Annual Review of Immunology
|
December 5, 2025
Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting
Hassane M Zarour, Giorgio Trinchieri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2022
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Diwakar Davar, Hassane M Zarour
Methods in Molecular Biology (Clifton, N.J.)
|
September 11, 2019
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors
Diwakar Davar, Hassane M Zarour
Clinics in Dermatology
|
April 24, 2013
Strategies to reverse melanoma-induced T-cell dysfunction
Julien Fourcade, Hassane M Zarour
Seminars in Cutaneous Medicine and Surgery
|
May 30, 2003
Melanoma vaccines: early progress and future promises
Hassane M Zarour, John M Kirkwood
Journal for Immunotherapy of Cancer
|
September 9, 2020
TIGIT in cancer immunotherapy
Joe-Marc Chauvin, Hassane M Zarour
Cellular and Molecular Bioengineering
|
July 10, 2026
Toward a Dual-Axis Model of Microbiome Modulation in Cancer Immunotherapy: Pathobiont Elimination and Functional Ecosystem Restoration
Diwakar Davar, Hassane M Zarour, Giorgio Trinchieri
Cell
|
April 17, 2026
Improving immunotherapy in solid tumors using FMT
Diwakar Davar, Hassane M Zarour, Georgio Trinchieri
Page
of 6